Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BA058 (abaloparatide), a parathyroid
hormone-related peptide, is effective in preventing fractures in postmenopausal women with
severe osteoporosis who are at risk of fractures.